Presentation Information
[O5-03E]Development of a live-attenuated vaccine candidate against severe fever with thrombocytopenia syndrome by a reverse genetic system.
*Rokusuke Yoshikawa1,2, Yasuteru Sakurai1,2, Jiro Yasuda1,2 (1. Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 2. National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University (Japan))

Comment
To browse or post comments, you must log in.Log in